REBECCA YOLOWITZ: Open Payments
NPI 1588272231 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 6 payments from 6 companies in 2025. Trend: 2023 $197 · 2024 $154 · 2025 $336
Education: $206Food & beverage: $129
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $111 |
| ABBVIE INC. | 1 | $95 |
| Genentech, Inc. | 1 | $56 |
| Celgene Corporation | 1 | $33 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $18 |
Products named: VENCLEXTA, Columvi, REBLOZYL, ULTOMIRIS, TECVAYLI.
Industry payments across MA — which companies pay providers there.
